CTSB and Alzheimer disease: Amyloid plaque pathology was significantly decreased by CTSB KO in these AD mice and was accompanied by decreased brain levels of Aβ1 - 40, Aβ1 - 42, pGlu-Aβ3 - 40, and pGlu-Aβ3 - 42 peptides [7, 10].